Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001635088-26-000137

President & Immunovant CEO sold 187,943 shares at an average $40.53 ($7,617,074)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Venker Eric President & Immunovant CEO 2026-11-10 Sale 10b5-1 −158,194 $40.44 $6,397,365 840,960 D
Venker Eric President & Immunovant CEO 2026-11-10 Sale 10b5-1 −29,749 $41.00 $1,219,709 811,211 D
Open-market sales · 187,943 sh · avg $40.53 · $7,617,074
Loading xslF345X06/wk-form4_1794528016.xml…